Recent progress of animal transplantation studies for treating articular cartilage damage using pluripotent stem cells. (20th January 2021)

• Record Type: Journal Article
• Authors: Yamashita, Akihiro; Tsumaki, Noriyuki
• Other Names: IKEYA M. guestEditor.; TOYOOKA Y. guestEditor.; EIRAKU M. guestEditor.
• Is Part Of: Development growth and differentiation. Volume 63:Number 1(2021)
• Page Start: 72
• Page End: 81
• Publication Date: 2021-01-20
• Subjects: cartilage -- pluripotent stem cells -- transplantation; Embryology -- Periodicals; Developmental biology -- Periodicals; Growth -- Periodicals; 574.3
• DOI: 10.1111/dgd.12706
• Languages: English
• ISSNs: 0012-1592

Abstract

Abstract: Focal articular cartilage damage can eventually lead to the onset of osteoarthritis with degradation around healthy articular cartilage. Currently, there are no drugs available that effectively repair articular cartilage damage. Several surgical techniques exist and are expected to prevent progression to osteoarthritis, but they do not offer a long‐term clinical solution. Recently, regenerative medicine approaches using human pluripotent stem cells (PSCs) have gained attention as new cell sources for therapeutic products. To translate PSCs to clinical application, appropriate cultures that produce large amounts of chondrocytes and hyaline cartilage are needed. So too are assays for the safety and efficacy of the cellular materials in preclinical studies including animal transplantation models. To confirm safety and efficacy, transplantation into the subcutaneous space and articular cartilage defects have been performed in animal models. All but one study we reviewed that transplanted PSC‐derived cellular products into articular cartilage defects found safe and effective recovery. However, for most of those studies, the quality of the PSCs was not verified, and the evaluations were done with small animals over short observation periods. Large animals and longer observation times are preferred. We will discuss the recent progress and future direction of the animal transplantation studies for the treatment of focal articular cartilage damages using PSCs. Abstract : To realize their clinical application, PSCs of clinical grade tested in appropriate animal transplantation models are recommended.